Happy City Holdings Limited Announces Closing of Initial Public Offering
Hong Kong, June 25, 2025 (GLOBE NEWSWIRE) -- Happy City Holdings Limited (Nasdaq: HCHL) (the 'Company'), an established all-you-can-eat hotpot restaurant operator in Hong Kong , announced the closing of its initial public offering (the 'Offering') of 1,100,000 Class A ordinary shares (the 'Class A Ordinary Shares'), at a price of $5.00 per Class A Ordinary Share (the 'Offering Price')
The Class A Ordinary Shares commenced trading on the Nasdaq Capital Market on June 24, 2025 under the symbol 'HCHL.'
The Company received aggregate gross proceeds of US$5.5 million from the Offering, before deducting underwriting discounts and other related expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 165,000 Class A Ordinary Shares of the Company, at the Offering Price, representing 15% of the Class A Ordinary Shares sold in the Offering (the 'Over-allotment Options').
The Company intends to use the net proceeds from the Offering for its business expansion in Hong Kong and Southeast Asia region and working capital and general corporate purposes.
The Offering was conducted on a firm commitment basis. Dominari Securities LLC acts as the representative of the underwriters, with Revere Securities LLC and Pacific Century Securities LLC acting as the co-underwriters (collectively, the 'Underwriters') for the Offering. Ortoli Rosenstadt LLP, Ogier, David Fong & Co. and China Commercial Law Firm act as United States, British Virgin Islands, Hong Kong and People's Republic of China legal counsels to the Company, respectively. AOGB CPA LIMITED acts as the reporting accountants of the Company. VCL Law LLP acts as legal counsel to the Underwriters for the Offering.
A registration statement on Form F-1 relating to the Offering was filed with the U.S. Securities and Exchange Commission (the 'SEC') (File Number: 333- 285856), as amended, and was declared effective by the SEC on May 30, 2025. The Offering was made by means of a prospectus, forming a part of the registration statement. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, copies of the prospectus relating to the Offering may be obtained, when available, from Dominari Securities LLC by email at info@dominarisecurities.com, by standard mail to Dominari Securities LLC, 725 Fifth Avenue, 23rd Floor New York, NY 10022, or by telephone at (212) 393-4500; or from Revere Securities LLC by email at contact@reveresecurities.com, by standard mail to Revere Securities LLC, 560 Lexington Avenue, 16th Floor, New York, NY 10022, or by telephone at +1 (212) 688-2350; or from Pacific Century Securities LLC by email at project@pcsecurities.us, by standard mail to Pacific Century Securities, LLC, 60-20 Woodside Avenue Ste 211 Queens, NY 11377, or by telephone at 212-970-8868.
Before you invest, you should read the prospectus and other documents the Company has filed or will file with the SEC for more information about the Company and the Offering. This press release has been prepared for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy any securities, and no sale of these securities may be made in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
About Happy City Holdings Limited
Headquartered in Hong Kong, we are a restaurant operator that operates three all-you-can-eat hotpot restaurants in Hong Kong serving mixed style, Shabu Shabu-style and Thai-style specialty hotpot. Through our restaurants that are located in various prime locations in Hong Kong, our unique brand image, and our strong commitment to food quality, we offer an immersive dining experience to our customers.
FORWARD-LOOKING STATEMENTS
Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations, including the trading of its Class A Ordinary Shares or the closing of the Offering. Investors can find many (but not all) of these statements by the use of words such as 'approximates,' 'believes,' 'hopes,' 'expects,' 'anticipates,' 'estimates,' 'projects,' 'intends,' 'plans,' 'will,' 'would,' 'should,' 'could,' 'may' or other similar expressions. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct. The Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to read the risk factors contained in the Company's final prospectus and other reports it files with the SEC before making any investment decisions regarding the Company's securities. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law.
ContactsHappy City Holdings LimitedInvestor RelationsEmail: info@happycitys.comSign in to access your portfolio
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
ALUULA Reports Second Quarter 2025 Financial Results
From windsports to wind power- ALUULA prepares for broader market growth Victoria, British Columbia--(Newsfile Corp. - June 25, 2025) - ALUULA Composites Inc. (TSXV: AUUA) ("ALUULA" or the "Company") today reported its financial results for the three and six month periods ended April 30, 2025 ("Q2 2025" and "YTD Q2 2025" respectively). All currency amounts noted are in Canadian dollars. Building on momentum from its first quarter, the Company continued to progress against its fiscal 2025 strategic initiatives during Q2 2025. ALUULA reported ongoing diversification of its customer base and sales pipeline, leveraged its expertise in kite design to advance leads in the wind power vertical market, and maintained gross margins within its target range. "This quarter is pivotal for us as we're turning towards a higher growth phase for the company," said Sage Berryman, President & CEO. "Our start in windsports has laid a strong technical and commercial foundation and we are building on that momentum to move into verticals such as wind power and beyond. We see the outlines of a future defined by high growth, diversification and broader market relevance. We are aligning our product innovation, our continued focus on circularity, our team, and partnerships to meet our growth potential." Key Q2 2025 Highlights Sales for Q2 2025 were $1,573,677 compared to $1,403,151 for the three-month period ended April 30, 2024 ("Q2 2024"), which represents a $170,526 or 12% increase. Sales increased across both of ALUULA's sales channels, with Performance Outdoor increasing by $113,935 and Commercial Industrial increasing by $56,591. The Company also continued to make progress against its customer diversification goals by: Reducing sales concentration with the windsport vertical market to 76% compared to 96% in Q2 2024. Continuing to diversify the sales pipeline with 100% of prototype size orders being generated by customers outside the windsport vertical market, compared to 94% in Q2 2024. Gross margins for Q2 2025 were 43% compared to 40% in Q2 2024, which is within the Company's expected range of 40%-45%. Operating expenses were $881,843 in Q2 2025 compared to $1,556,493 in Q2 2024 representing a decrease of $674,650. Operating expenses in Q2 2024 were higher due to costs incurred to effect organizational changes including $390,000 in severance payments and $50,000 in general & administration ("G&A") costs resulting from the write off of patents and trademarks no longer needed to support the Company's future growth. Also contributing to higher G&A costs in Q2 2024 were warranty provisions recorded for older materials with higher-than-average warranty rates. Other Income was $15,540 in Q2 2025 compared to $752,379 in Q2 2024 representing a decrease of $736,839. In Q2 2024, Other Income included a fair value adjustment of $749,391 associated with the Company's investment in Xlynx Materials Inc. common shares (the "Xlynx Shares"). The fair value adjustment was based on the sale price negotiated for the Xlynx Shares in a May 2024 purchase and sale agreement. Net and comprehensive loss from Ocean Rodeo's discontinued operations was $60,936 Q2 2025 compared to a net and comprehensive loss of $394,680 in Q2 2024 representing a decrease of $333,744. This decrease is a direct result of cost cutting measures implemented in April 2024 after the decision was made to discontinue Ocean Rodeo's operations. Key YTD Q2 2025 Highlights Sales for YTD Q2 2025 were $2,835,206 compared to $3,400,430 during YTD Q2 2024, which represents a decrease of $565,224 or 17%. The decrease in YTD Q2 2025 sales is due to timing of receipt of windsport customer orders, which varied significantly across fiscal 2024 quarters and are expected to be more consistent throughout fiscal 2025, a trend that is holding true through the six-month period ending April 30, 2025. Gross margins for YTD Q2 2025 were 43%, which was consistent with the YTD Q2 2024 period and within the Company's expected range of 40%-45%. Operating expenses were $1,701,373 in YTD Q2 2025 compared to $2,239,525 in Q2 2024 representing a decrease of $538,152. Operating expenses in YTD Q2 2024 were higher due to costs incurred to effect organizational changes detailed earlier in this press release. The Company also reported a $106,723 reduction in marketing expenses in YTD Q2 2025 due to the decision not to exhibit at two tradeshows in Germany that were attended in YTD Q2 2024. Net and comprehensive loss from Ocean Rodeo's discontinued operations was $66,331 in YTD Q2 2025 compared to a net and comprehensive loss of $741,237 in YTD Q2 2024 representing a decrease of $674,906. This decrease is a direct result of cost cutting measures implemented in April 2024 after the decision was made to discontinue Ocean Rodeo's operations. Outlook The Company continues to work with its growing list of brand partners, developing products that are lighter, stronger, and recycle-ready. These partnerships are built on the mutual understanding that performance and circularity can be synonymous in the outdoor industry and beyond. The products that are born from these partnerships work to change their respective industries for the better. The Windsport and other Performance Outdoor categories are still the core drivers of ALUULA's growth as more companies move from concept into commercialization, launching new ALUULA-enabled products. Collaborative research and development programs with other industrial partners, such as Michelin Inflatable Solutions and AirSeas, continue to advance the materials' development as these opportunities move towards commercial application. While these existing opportunities continue to progress, the Company is also prioritizing proactive sales outreach in large and growing markets where strong product fit exists and ALUULA's high-performance materials enable uses not possible with incumbent materials. This includes focusing on Commercial Industrial applications such as renewable energy sources (wind power is one example, with the current drive towards decarbonization of the shipping industry) and defense applications (such as ultra-light and ultra-strong sustainable portable shelters, particularly for extreme cold environments). With the Company's corporate foundation now stabilized, ALUULA is focused on key areas including sales pipeline expansion, product innovation, and circularity. The Company has prioritized these areas as well as continued improvements to the patented manufacturing process, as it expects them to contribute to improved efficiencies and profitability. All of these operational aspects will work together to achieve ALUULA's mission, which is to help instigate a global composite textile revolution and prove that high-performance and circularity are synonymous. Financial Statements and Management's Discussion and Analysis This earnings press release should be read in conjunction with ALUULA's unaudited interim condensed consolidated financial statements for the six months ended April 30, 2025 and the related management discussion and analysis, which can be found on ALUULA's website and its issuer profile on the System for Electronic Document Analysis and Retrieval Plus at About ALUULA Composites ALUULA is an ultra-light, high performance and recycle-ready composite materials brand that enhances the performance of outdoor gear. Proudly owned and manufactured on the Canadian west coast, ALUULA's innovation is driven by a deep understanding that equipment does not need to sacrifice performance for sustainability. ALUULA's materials are known for their unique construction capabilities and their ability to make products lighter, stronger, and more sustainable. | (TSXV: AUUA) On behalf of the Board of Directors,Sage BerrymanChief Executive Officer1-888-724-2470 For ALUULA investor inquiries, please contact: 1-888-724-2470, ext. 4 IR@ For ALUULA media relations, please contact: media@ ALUULA's Brand Partners The term "brand partners" does not refer to formal partnerships with our customers. The term refers to marketing relationships with our customers who use ALUULA's technology as a brand ingredient in their products. TSX Venture Exchange Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements The information in this news release includes certain information and statements about management's view of future events, expectations, plans, and prospects that constitute forward-looking statements, including, but not limited to: the Company's list of brand partners growing; the Company's advancement of its materials development; the Company's future focus on Commercial Industrial and defense applications; ; the Company achieving its mission. These statements are based on assumptions subject to significant risks and uncertainties as described in the Company's management discussion and analysis. Because of these risks and uncertainties and as a result of a variety of factors, including the timing and receipt of all applicable regulatory, corporate third-party approvals, the actual results, expectations, achievements, or performance may differ materially from those anticipated and indicated by these forward-looking statements. Although the Company believes that the expectations reflected in forward-looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statement will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
35 minutes ago
- Yahoo
Why a billionaire investor thinks bitcoin's total market value could more than double to $5 trillion
Philippe Laffont, the founder of hedge fund Coatue, thinks bitcoin's market value could soar to $5 trillion. His forecast implies bitcoin's market cap more than doubling from its $2.1 trillion level. Laffont said there are several reasons he's become more bullish on the crypto. The total value of all bitcoins could more than double, according to one billionaire investor who says he wishes he had bought the crypto sooner. Philippe Laffont, the founder of hedge fund Coatue Management, said he added bitcoin to his firm's Fantastic 40 list, a collection of investments it sees as major winners through 2030. That's partly because Laffont believes the total market cap of the world's biggest crypto could rise to as much as $5 trillion one day. That implies bitcoin's total value rising 134% from a market cap of around $2.1 trillion on Wednesday. "I have not gotten involved in bitcoin. I wake up every day at 3 in the morning and I'm like, 'why am I such an idiot? What have I been waiting for, not being involved in it?' And it just goes up and up," Laffont told CNBC on Wednesday. Bitcoin's price has been volatile this year amid tariff-related volatility and a mix of geopolitical and economic concerns. The crypto has rallied to $107,000 in recent days, bringing its price up 14% year-to-date. It hit an all-time high above $111,000 in May. This embedded content is not available in your region. Laffont, who said he initially brushed off bitcoin as an attractive investment, added that there were a few reasons why he's warming up to the cryptocurrency and sees the value soaring. For one, bitcoin's current valuation relative to the rest of the world seems too low, according to Laffont. The net worth of all world assets hovers around $500 trillion, Laffont said. That means bitcoin represents around 0.5% of the world's total assets, but Laffont thinks it's reasonable for bitcoin to represent 1%-2% of the total. Global stocks, by comparison, make up around $120 trillion of the world's assets, while gold makes up around $20 trillion, he added. Second, bitcoin's volatility appears to be declining relative to stocks. Bitcoin dropped 11% in the days after President Donald Trump announced his sweeping array of tariffs. That's a slightly less severe decline when compared to the Nasdaq 100, which dropped 12% from April 2 to its low on April 8. "I always thought, bitcoin's amazing, but it's double or triple the volatility of the Nasdaq," Laffont said. "It seems its volatility as an asset class is coming down." Third, bitcoin could benefit from concerns around de-dollarization and the end of US exceptionalism. Global investors have shown some signs that they're less willing to park their wealth in US assets after this year's tariff-fueled sell-off. More than half of global investors surveyed by Bank of America in June said they believed international equities would be the best-performing asset over the next five years, compared to just 23% of investors who said they believed US equities would be the top performer. The US Dollar Index, which measures the dollar against a basket of foreign currencies, has also declined 10% year-to-date. Laffont said he was now considering purchasing bitcoin. "Do I own it now? Do I own it tomorrow or in a few days? But every day, I do think, 'Why do I not own it?'" Laffont said. "Sometimes you have to change your mind and you have to say, well, I made a mistake," he added. Read the original article on Business Insider Sign in to access your portfolio
Hamilton Spectator
38 minutes ago
- Hamilton Spectator
PSYENCE GROUP INC. Announces Update on Previously Announced Non-Brokered Private Placement of Common Shares
TORONTO, June 25, 2025 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG) ('Psyence' or the 'Company'), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the 'Offering') of common shares in the capital of the Company (the 'Common Shares'). Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of C$0.10 per Common Share for gross proceeds of C$476,000. Tranche 2 is anticipated to close on or about July 4, 2025 for the remaining gross proceeds of C$124,000. The Offering was originally announced on June 18, 2025. The net proceeds of the Offering will be used for general working capital purposes. The Offering was completed pursuant to the prospectus exemption available under Section 2.3 of National Instrument 45-106 – Prospectus Exemptions (the 'accredited investor' exemption) and other available exemptions under applicable securities laws. All securities issued in connection with the Offering are subject to a statutory hold period of four months and one day from the date of issuance in accordance with applicable Canadian securities laws. In the event that the Company undertakes a transaction that constitutes a fundamental change, change of business, reverse takeover, or other reviewable transaction as defined under applicable securities laws and policies of the Canadian Securities Exchange, or raises additional funds through a public offering, private placement, or other capital raise involving equity or equity-linked instruments, the resale restrictions may extend beyond four months and one day following the completion of such transaction. There can be no assurance that any transaction will be identified or completed, and the Company may reallocate the use of proceeds depending on evolving business needs and market conditions. ABOUT PSYENCE GROUP: Psyence is a life science biotechnology company listed on the Canadian Securities Exchange (CSE: PSYG), with a focus on natural psychedelics. Psyence works with nature-derived psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. Our name 'Psyence' combines the words psychedelic and science to affirm our commitment to producing psychedelic medicines developed through evidence-based research. Informed by nature and guided by science, Psyence works to develop advanced nature-derived psilocybin products for clinical research and development. Contact Information Learn more at Email: ir@ Media Inquiries: media@ General Information: info@ Phone: +1 416-477-1708 FORWARD LOOKING STATEMENTS: Certain statements in this news release related to the Company are forward-looking statements and are prospective in nature. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. These statements generally can be identified by the use of forward-looking words such as 'may', 'should', 'could', 'intend', 'estimate', 'plan', 'anticipate', 'expect', 'believe' or 'continue', or the negative thereof or similar variations. There are numerous risks and uncertainties that could cause actual results and the Company's plans and objectives to differ materially from those expressed in the forward-looking information. These risks and uncertainties include the successful closing of the second tranche of the Offering, the successful deployment of the Offering proceeds and the identification of opportunities in the market. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements. The Company makes no medical, treatment or health benefit claims about the Company's proposed products. The U.S. Food and Drug Administration, Health Canada or other similar regulatory authorities have not evaluated claims regarding psilocybin, psilocybin analogues, or other psychedelic compounds or nutraceutical products. The efficacy of such products has not been confirmed by approved research. There is no assurance that the use of psilocybin, psilocybin analogues, or other psychedelic compounds or nutraceuticals can diagnose, treat, cure or prevent any disease or condition. Vigorous scientific research and clinical trials are needed. The Company has not conducted clinical trials for the use of its proposed products. Any references to quality, consistency, efficacy, and safety of potential products do not imply that the Company verified such in clinical trials or that the Company will complete such trials. If the Company cannot obtain the approvals or research necessary to commercialize its business, it may have a material adverse effect on the Company's performance and operations.
